Kutsu Turvatiimi Oyj:n varsinaiseen yhtiökokoukseen
February 14, 2013 07:50 ET
|
Turvatiimi
Turvatiimi Oyj Pörssitiedote 14.2.2013 klo 14.50
Turvatiimi Oyj:n osakkeenomistajat kutsutaan varsinaiseen...
Pieno Zvaigzdes AB information
February 14, 2013 07:45 ET
|
Pieno Zvaigzdes
Vilnius, Lithuania, 2013-02-14 13:45 CET (GLOBE NEWSWIRE) --
Pieno zvaigzdes notifies that the company have no deposits or securities in Ukio bankas AB, therefore the 12th February 2013 resolution...
Government Securities Auction Results - 13 and 14 February (Additional information on 14 February)
February 14, 2013 07:43 ET
|
Valsts Kase
On Wednesday, 13 February, three-year domestic government bonds were offered with maturity 11 January, 2016. Total demand for government 3-yr T-Bonds in competitive multi-price auction achieved...
SATO julkaisi vuosikertomuksen myös verkossa
February 14, 2013 07:40 ET
|
SATO Oyj
Helsinki, Finland, 2013-02-14 13:40 CET (GLOBE NEWSWIRE) --
SATO Oyj, lehdistötiedote, 14.2.2013 klo 14.39
SATOn vuosikertomus vuodelta 2012 on ilmestynyt. Julkaisimme nyt ensimmäistä kertaa...
Land & Leisure A/S - Periodemeddelelse for perioden 01.10.2012 - 31.12.2012
February 14, 2013 07:37 ET
|
Land & Leisure A/S
...
Holding(s) in Company
February 14, 2013 07:36 ET
|
Vast Resources PLC
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;}TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi1....
SWECO AB (publ)Year-end report 2012
February 14, 2013 07:30 ET
|
SWECO AB
Strong growth and record earnings
OCTOBER – DECEMBER 2012
· Net sales of SEK 2,093.5 million (1,786.1).
· Operating profit of SEK 182.5 million (191.6).
· Operating margin of 8.7 per cent...
SWECO AB (publ) Bokslutskommuniké 2012
February 14, 2013 07:30 ET
|
SWECO AB
Stark tillväxt och rekordresultat
OKTOBER – DECEMBER 2012
· Nettoomsättningen uppgick till 2 093,5 MSEK (1 786,1).
· Rörelseresultatet uppgick till 182,5 MSEK (191,6).
· Rörelsemarginalen blev...
Amicus Therapeutics Advances Chaperone-Enzyme Replacement Therapy (ERT) Combination Platform in Pompe Disease
February 14, 2013 07:30 ET
|
Amicus Therapeutics, Inc.
Phase 2 AT2220-ERT Co-Administration and Preclinical AT2220-ERT Co-Formulation Studies Presented at LDN WORLD Symposium
Next-Generation ERT Advancing in Preclinical Studies
Conference Call...
Digirad Corporation to Release 2012 Fourth Quarter and Year-End Results on February 28, 2013
February 14, 2013 07:30 ET
|
Digirad Corporation
POWAY, Calif., Feb. 14, 2013 (GLOBE NEWSWIRE) -- Digirad Corporation (Nasdaq:DRAD) will release financial results for its fourth quarter and year ended December 31, 2012, before the market opens on...
- September 19, 2024 08:14 ET Helping Ukraine Preserve Cultural Heritage through the ARK Project
- September 19, 2024 08:05 ET Filevine’s LEX Summit 2024: A Landmark Event for the Legal Industry